异动解读 | Staar Surgical Company盘中股价暴跌5.07%,分析师下调目标价

异动解读
14 Feb

Staar Surgical Company(STAA)今日盘中股价暴跌5.07%,引发市场广泛关注。

从相关新闻来看,两家分析机构当日大幅下调了该公司的目标股价,这可能是导致股价大跌的主要原因。数据显示,Canaccord Genuity将STAA的目标价从28美元下调至17美元,摩根士丹利则将其目标价从23美元大幅下调至13美元。

分析师下调目标价,反映了他们对公司未来业绩的担忧。虽然Staar Surgical目前尚未公布最新财报,但其上一季度业绩表现欠佳,净利润为-2021万美元,亏损比上年同期扩大。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10